ABSTRACT. We have examined the mechanisms that prevent the induction of oral tolerance to protein antigens in neonatal mice. Serum collected from adult mice 1 h after feeding ovalbumin (1 mg/g body wt) was adoptively transferred to mice aged 1, 3, and 42 d (40 P L /~ body wt). Whereas delayed-type hypersensitivity was significantly suppressed in adult recipients relative to control groups, no suppression of systemic delayed-type hypersensitivity was found in neonatal recipients. In attempts to identify the immunologic deficiency that prevents mature reactivity to protein antigens in neonates, adult splenocytes were transferred intraperitoneally (10' cells/recipient) 24 h before a feed of OVA (1 mg/g body wt) to neonates. Significant suppression of their systemic DTH response, but not of their anti-ovalbumin IgG antibody response was observed, indicating that spleen cell transfer only partially confers adult-type reactivity. Similar results were obtained using a second protein antigen, BSA. Our observations suggest that the failure to induce oral tolerance to protein antigens in neonatal mice is not simply due to immature antigen processing by the gut, but probably reflects cellular and/or antigen handling immaturity of the neonatal immune system. (Pediatr Res 26:486-490, 1989) 
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antigen handling or in the induction of antigen specific suppressor T cells may be responsible (1, 12, 14) . Indeed, such proposals are supported by recent reports that have shown that oral tolerance cannot be induced in neonatal mice fed with OVA at a wtrelated dosage known to produce tolerance in adult mice (2, 5, 14) .
We and others (1 5-18) have previously shown that adoptive transfer of serum collected after feeding OVA induces antigenspecific suppression of systemic DTH in adult mice. In our study we have used two experimental approaches to investigate the possible role of gut processing and immaturity of the neonatal immune system on the induction of oral tolerance. First, we transferred "gut-processed" tolerogenic OVA from adult mice to both mature and neonatal recipients, and second, we attempted to "educate" the immune system of the neonate with adult spleen cells before antigen administration to investigate whether this procedure would permit the induction of oral tolerance in neonates.
MATERIALS A N D METHODS
General experimental protocol. The general protocol for all the experiments performed is outlined in Table 1 .
Animals. Adult (8 to 10 wk old) BALB/c mice, purchased from Charles River U.K. Ltd. (Margate, Kent), were used as breeding stock for a new colony in the Animal House, Institute of Child Health, London. Close to the expected date of delivery, pregnant mice were checked twice per day (1000-1800 h) and the offspring were treated within the first 24 h of life. Mice were maintained on a standard laboratory diet (CRM (X); Labsure Ltd., Manea, Cambridgeshire, U.K.) containing neither OVA nor bovine albumin. All colony-bred mice were weaned onto this standard diet at 21 d of age. Young (6 to 8 wk old) female BALB/c mice (Charles River, U.K. Ltd.) were used either as adult controls or as donors for both serum and spleen cell transfer experiments.
Antigens. OVA (grade V) and BSA Fraction V) were obtained from Sigma Chemical Co. (Poole, Dorset, U.K.).
Oral administration of antigen. Both OVA and BSA were dissolved in 0.15 M saline and prepared at two different concentrations: 1) 100 mg/mL (1 mg/g body wt of adult mice): 0.25 mL/feed; 2) 30 mg/mL (1 mg/g body wt of neonatal mice): 0.05 mL/feed. Neonatal mice were fed by gentle gavage using an intravenous tube (Code 00; Portex Ltd., Hythe, Kent, U.K.) attached to a 28-gauge needle stock. To minimize trauma, the end of the feeding tube was blunted by heating and checked for smoothness under a light microscope. Adult mice were also fed by gavage using an 18-gauge feeding tube with a rounded tip (Fine Science Tools Inc., North Vancouver, B.C., Canada). Mice in the experimental groups were fed with OVA or BSA, and those in the control groups were fed with saline only. Animals that showed signs of regurgitation or bleeding after feeding were excluded. Adoptive transfer of serum. Donor mice were fed wiLh 25 mg OVA dissolved in 0.25 mL saline or with 0.25 mL saline only. Under halothane anaesthesia, the mice were exsanguinated by cardiac puncture 1 h after feeding. The sera of aniinals in the OVA-fed or saline-fed groups were pooled separately and injected i.p. into recipient animals at a dosage of 40 pL/g body wt (15) (16) (17) (18) . Two groups of control animals received injections of either saline alone or pooled normal mouse serum "spiked" with OVA (70 ng/mL) and incubated under continuous rotation for 1 h at 37°C. The latter concentration was derived from preliminary experiments (Peng H-J, Turner MW, and Strobe1 S, unpublished observations).
Animals in each of the four treatment groups were subsequently immunized as described below.
Adoptive transfer of spleen cells. Under halothane anaesthesia, spleens were removed from naive adult mice and placed into RPMI 1640 (GIBCO, Paisley, Scotland). Spleen cells were liberated from the splenic capsule using RPMI 1640 in a 1-mL syringe with a 25-gauge needle. Thereafter, spleen cells were washed three times and injected i.p. into neonatal mice within 24 h of birth (lo8 viable cells in 0.1 mL RPMI 1640 per recipient).
Systemic immunization. Mice were parenterally immunized in the left hind footpad with 100 pg OVA or BSA emulsified in 0.05 mL complete Freund's adjuvant (Bacto H37Ra, Difco Labs., West Molesey, Surrey, U.K.). Neonatal mice were not immunized until 4 wk old, whereas adult animals were immunized 7 d after the transfer of serum.
Assessment of specijic IgG antibody responses. Mice were bled from the tail 20 d after immunization. The separated serum was stored frozen at -20°C until required. Serum anti-OVA IgG antibodies were assayed by an ELISA (19) . In brief, flat-bottomed microtitre plates (Linbro, Flow Labs. Ltd., Rickmansworth, Herts., U.K.) were coated with OVA (100 pg/mL) dissolved in 0.05 M carbonate buffer pH 9.6 (100 pL/well) overnight at 4°C and free sites on the plates were blocked with 1% goat serum.
After six washes, serum samples ( 1 / 1000) and standards (affinitypurified mouse anti-OVA IgG), both diluted in saline-Tween containing 1% goat serum, were incubated for 1.5 h at 37°C. After washing, 100 pL of a 1/5000 dilution of alkaline phosphatase conjugated goat antimouse IgG (Fc-specific; Jackson Im-. munoresearch Labs., West Grove, PA) were added and the plates incubated for 1.5 h at 37°C. After the final washes, p-nitrophenylphosphate (1 mg/mL; Sigma) was added and the absorbance read at 405 nm in a Titertek Multiskan ELISA Reader (Flow Labs.).
A n t i -~s A IgG antibodies were assessed in a similar ELISA. Briefly, plates were coated with BSA (100 pg/mL) overnight at room temperature. Free sites on the plates were blocked with OVA Tween, serum samples ( 1/ 1000), and standards (0-2000 ng/mL affinity-purified mouse anti-BSA IgG), diluted in salineTween, were incubated in duplicate in the wells for 1.5 h at 37°C. All the other steps in the procedure were the same as those in the ELISA for IgG anti-OVA antibodies.
Measurement of systemic DTH responses. Three wk after systemic immunization, the systemic DTH response was determined by a footpad swelling test. Mice received injections into the right hind footpad with 100 pg BSA or heat-aggregated OVA in 0.05 mL sterile saline. The footpad thickness was measured using a dial thickness gauge (Mitutoyo, MFG Co., Tokyo, Japan) both before and 24 h after challenge. The differences between these two measurements were used in the group comparisons.
Statistics. Both IgG antibody and systemic DTH responses were expressed as means + 1 SD and all group comparisons were made using unpaired Student's t tests.
RESULTS
Immunologic effects of adoptive transfer of "gut-processed" OVA. Groups of neonatal or adult recipients received i.p. injections with either 1 ) saline, 2) serum from saline-fed animals, 3) serum "spiked" with OVq, or 4) serum from OVA-fed animals (see Table 1 , protocol A). Three weeks after this systemic im. mice receiving saline or any of the serum preparations ( p > 0.05; (Fig. 1) .
Adult recipients receiving serum collected from OVA-fed donors had significantly lower systemic DTH responses than mice receiving serum from saline-fed donors or mice receiving serum spiked with OVA ( p < 0.005 for both comparisons; Fig. 2 ). In addition, there was a significantly reduced DTH response compared to mice receiving saline injections ( p < 0.05). In contrast, there were no differences between the systemic DTH responses of the four neonatal experimental groups ( p > 0.05 for all comparisons; Fig. 2 ). This suggests that adoptive transfer of "gutprocessed" OVA from adult mice to neonatal mice does not confer systemic DTH tolerance. Neonatal animals that had received adult spleen cells before transfer of the "tolerogenic" serum (see Table 1 , protocol Bl) did not develop suppression of either antibodies or DTH (data not shown).
Effects of transfer of adult spleen cells on induction of oral tolerance in neonatal mice. Neonatal mice, which had received either lo8 adult spleen cells or culture medium on the first day of life, were fed the next day with either saline or OVA (Table 1 , protocol B2). Four weeks later they were systemically immunized with OVA in CFA. Three weeks after immunization their serum IgG anti-OVA antibody and DTH responses were assessed (Fig.  3) .
There was no significant difference between any two groups in the levels of specific IgG antibody to OVA, although feeding a protein antigen to newborn mice might be expected to prime the animals.
In contrast, the neonatal mice receiving adult splenocytes on d 1 and a feed of OVA on d 2 showed a lower DTH response than any other experimental group (p < 0.00 1-<0.02; Fig. 3b ).
Neonatal mice, which had received either lo8 adult spleen cells or 0.1 mL RPMI 1640 on the first day of life, were fed the next day with either saline or BSA. Four wk later they were systemically immunized with BSA in CFA. Three weeks after immunization their serum IgG anti-BSA antibody and DTH responses were measured (Fig. 4) .
The mice receiving lo8 adult spleen cells on d 1 and a feed of BSA on d 2 showed a significantly lower DTH response than mice in the other treatment groups ( p < 0.001-<0.05; Fig. 4b ).
However, the specific IgG antibody responses of these groups of animals did not differ ( p > 0.05; Fig. 4a ).
DISCUSSION
Previous studies (2, 5, 15) have shown that oral antigen administration to neonatal mice does not lead to oral tolerance and we have speculated that this might be due to the immaturity of the antigen-processing capacity of the neonatal gut. The experiments reported here, however, show that transfer to neonates of serum containing tolerogenic ovalbumin moieties generated by the adult gastrointestinal tract does not induce systemic hyporesponsiveness of DTH in neonatal mice, whereas it is immunologically active in mature animals. In contrast, antibody responses are not affected in either mature or immature recipients.
Adoptive transfer of spleen cells from adult to neonatal mice permits the recipients to develop systemic hyporesponsiveness for DTH but not for antibody responses to orally administered proteins. Complete oral tolerance would require suppression of both limbs of the systemic immune response. The study of two different proteins suggests that the results reported here are representative for thymus-dependent protein antigens.
DTH tolerance can be transferred to adult naive mice with serum collected 1 h after feeding OVA (15) (16) (17) (18) . The amount of immunoreactive OVA circulating 1 h after feeding 1 mg/g body wt varies considerably (approximate range 60-100 ng/mL ( 17) (Peng H-J, Turner MW Strobe1 S, unpublished observations). Addition of such amounts of native OVA to normal mouse serum followed by incubation for 1 h at 37°C does not confer tolerogenic activity to the serum and does not lead to suppression of cell-mediated immunity. This indicates that the tolerogenicity of the serum is not directly related to the amount of immunoreactive antigen detected by ELISA.
Several reports suggest that antigen processing by the neonatal are generally suppressed after a protein feed; the transfer of spleen cells to neonates, however, only restores mature reactivity to DTH responses. The reasons for this apparent discrepancy remain unclear. Differences in the characteristics of induction and duration of the suppression of both limbs of the immune re.-sponse have been reported (1, 19, 27 ). An additional finding was that even high dose spleen cell transfer failed to induce tolerance of systemic DTH after adoptive serum transfer. Further studies with graded doses of purified T lymphocytes or accessory cells are needed to examine whether these phenomena are due to a deficiency in antigen presentation. Further insight into the immunochemical and cellular modulation of these immunoregulatory pathways is of potential clinical importance in the prophylaxis and/or therapy of hypersensitivity diseases and in the development of oral vaccines.
intestine is immature and both 'nefiicient luminal proteolysis ~~k~~ The authors thank the staKof the Institute and increased gut permeability have been described (5, 13, 20) . of child ~~~l~h A~~~~I H~~~~ for their help and ~i~~ ~~i~ We have therefore transferred adult gut processed proteins to Hanstater for preparing the manuscript, both adult and neonatal mice. Suppression of DTH responses was always observed in adult recipients but was never seen in neonatal recipients. These results suggest that immaturity of intestinal antigen processing is not the sole factor preventing the induction of oral tolerance in neonatal mice; other host factors possibly associated with the ontogeny of the immune system are of greater importance. Although the nature of intestinal antigen processing is unknown, the production of gut processed tolerogenic OVA has been shown to be abrogated in lethally irradiated mice (18) . However, those mice have a variety of mucosal and immunologic abnormalities that include substantial T lymphocyte depletion of their lymphoid tissues. In a previous report (1 8) , the capacity of the gut to create "tolerogens" could be restored by injection of normal spleen cells. This suggests that cells residing in the spleen may also be involved in the phenomenon of "antigen processing" or antigen presentation. In a different experimental system evaluating IgE responses after antigen inhalation, Holt et al. (21) recently reported a similar effect.
These authors were unable to induce inhalation tolerance in neonatal rats but the transfer of adult spleen cells restored the capacity to induce antigen-specific inhalation tolerance.
Our results support the view that the immature immune system of the neonate can be partially modified to a mature pattern of reactivity 24 h after transfer of adult spleen cells. It is feasible that neonatal mice lack a specific suppressor T cell network otherwise activated by orally administered antigens or by adoptive transfer of gut-processed antigen. In addition, other factors such as natural suppressor cells or suppressor factors (22) , high levels of a-fetoprotein (23), a deficiency in antigen presentation (24) , or deficient production of cytokines (25, 26) , may play a role in the prevention of neonatal induction of oral tolerance.
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